These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 39000607)
21. APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA. Schmidt KN; Leung B; Kwong M; Zarember KA; Satyal S; Navas TA; Wang F; Godowski PJ J Immunol; 2004 Jan; 172(1):138-43. PubMed ID: 14688319 [TBL] [Abstract][Full Text] [Related]
22. The anti-tumor role of NK cells in vivo pre-activated and re-stimulated by interleukins in acute lymphoblastic leukemia. Jin F; Lin H; Gao S; Hu Z; Zuo S; Sun L; Jin C; Li W; Yang Y Oncotarget; 2016 Nov; 7(48):79187-79202. PubMed ID: 27816971 [TBL] [Abstract][Full Text] [Related]
23. VTX-2337 is a novel TLR8 agonist that activates NK cells and augments ADCC. Lu H; Dietsch GN; Matthews MA; Yang Y; Ghanekar S; Inokuma M; Suni M; Maino VC; Henderson KE; Howbert JJ; Disis ML; Hershberg RM Clin Cancer Res; 2012 Jan; 18(2):499-509. PubMed ID: 22128302 [TBL] [Abstract][Full Text] [Related]
24. Dendritic cells and NK cells stimulate bystander T cell activation in response to TLR agonists through secretion of IFN-alpha beta and IFN-gamma. Kamath AT; Sheasby CE; Tough DF J Immunol; 2005 Jan; 174(2):767-76. PubMed ID: 15634897 [TBL] [Abstract][Full Text] [Related]
25. Enhanced interaction between natural killer cells and lung cancer cells: involvement in gefitinib-mediated immunoregulation. He S; Yin T; Li D; Gao X; Wan Y; Ma X; Ye T; Guo F; Sun J; Lin Z; Wang Y J Transl Med; 2013 Aug; 11():186. PubMed ID: 23937717 [TBL] [Abstract][Full Text] [Related]
26. MicroRNA-30c promotes natural killer cell cytotoxicity via up-regulating the expression level of NKG2D. Ma Y; Gong J; Liu Y; Guo W; Jin B; Wang X; Chen L Life Sci; 2016 Apr; 151():174-181. PubMed ID: 26968781 [TBL] [Abstract][Full Text] [Related]
27. Innate Immune Responses of Vaccinees Determine Early Neutralizing Antibody Production After ChAdOx1nCoV-19 Vaccination. Shen CF; Yen CL; Fu YC; Cheng CM; Shen TC; Chang PD; Cheng KH; Liu CC; Chang YT; Chen PL; Ko WC; Shieh CC Front Immunol; 2022; 13():807454. PubMed ID: 35145520 [TBL] [Abstract][Full Text] [Related]
28. Interaction of Mycobacterium tuberculosis cell wall components with the human natural killer cell receptors NKp44 and Toll-like receptor 2. Esin S; Counoupas C; Aulicino A; Brancatisano FL; Maisetta G; Bottai D; Di Luca M; Florio W; Campa M; Batoni G Scand J Immunol; 2013 Jun; 77(6):460-9. PubMed ID: 23578092 [TBL] [Abstract][Full Text] [Related]
30. Human natural killer cells expressing the memory-associated marker CD45RO from tuberculous pleurisy respond more strongly and rapidly than CD45RO- natural killer cells following stimulation with interleukin-12. Fu X; Liu Y; Li L; Li Q; Qiao D; Wang H; Lao S; Fan Y; Wu C Immunology; 2011 Sep; 134(1):41-9. PubMed ID: 21711347 [TBL] [Abstract][Full Text] [Related]
31. In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients. Konjević G; Mirjačić Martinović K; Vuletić A; Babović N Melanoma Res; 2010 Dec; 20(6):459-67. PubMed ID: 20938360 [TBL] [Abstract][Full Text] [Related]
32. Coordinated Activation of Toll-Like Receptor8 (TLR8) and NLRP3 by the TLR8 Agonist, VTX-2337, Ignites Tumoricidal Natural Killer Cell Activity. Dietsch GN; Lu H; Yang Y; Morishima C; Chow LQ; Disis ML; Hershberg RM PLoS One; 2016; 11(2):e0148764. PubMed ID: 26928328 [TBL] [Abstract][Full Text] [Related]
33. Chemokine, cytokine and type I interferon production induced by Toll-like receptor activation in common variable immune deficiency. Lollo C; de Moraes Vasconcelos D; Oliveira LMDS; Domingues R; Carvalho GC; Duarte AJDS; Sato MN Clin Immunol; 2016 Aug; 169():121-127. PubMed ID: 27392462 [TBL] [Abstract][Full Text] [Related]
34. Celiac Disease-Related Inflammation Is Marked by Reduction of Nkp44/Nkp46-Double Positive Natural Killer Cells. Marafini I; Monteleone I; Di Fusco D; Sedda S; Cupi ML; Fina D; Paoluzi AO; Pallone F; Monteleone G PLoS One; 2016; 11(5):e0155103. PubMed ID: 27171408 [TBL] [Abstract][Full Text] [Related]